GENEVA, July 6 -- HIKMA PHARMACEUTICALS USA INC. filed a patent application (US2025/060397) for “FORMULATIONS FOR INJECTABLE COMBINATION PRODUCT CONTAINING ACETAMINOPHEN AND IBUPROFEN”. With publication no. WO/2026/142931, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/192
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....